Aztreonam

Products

Aztreonam is commercially available as a dry substance for parenteral administration (Azactam) and as an inhalation solution (Cayston). It has been approved in many countries since 1986.

Structure and properties

Aztreonam (C₁₃H₁₇N₅O₈S₂, M_r = 435.4 g/mol)

Effects

Aztreonam (ATC J01DF01) is antibacterial against Gram-negative aerobic bacteria, including .

Indications

• For parenteral treatment of bacterial infectious diseases.
• For suppressive treatment of chronic pulmonary infections with in patients with cystic fibrosis.